These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18364501)

  • 41. Research methodology and analytic techniques used in the Journal Obstetrics & Gynecology.
    Dauphinee L; Peipert JF; Phipps M; Weitzen S
    Obstet Gynecol; 2005 Oct; 106(4):808-12. PubMed ID: 16203723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methodological and statistical problems in uvulopalatopharyngoplasty research: a follow-up study.
    Megwalu UC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Aug; 134(8):805-9. PubMed ID: 18711052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DISPACT trial: a randomized controlled trial to compare two different surgical techniques of DIStal PAnCreaTectomy - study rationale and design.
    Diener MK; Knaebel HP; Witte ST; Rossion I; Kieser M; Buchler MW; Seiler CM;
    Clin Trials; 2008; 5(5):534-45. PubMed ID: 18827046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of surgical randomized controlled trials for acute cholecystitis: assessment based on CONSORT and additional check items.
    Shikata S; Nakayama T; Yamagishi H
    J Hepatobiliary Pancreat Surg; 2008; 15(3):297-303. PubMed ID: 18535768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials.
    Flemming K; Adamson J; Atkin K
    Palliat Med; 2008 Mar; 22(2):123-31. PubMed ID: 18372377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.
    Le Cleach L; Chassany O; Levy A; Wolkenstein P; Chosidow O
    Dermatology; 2008; 216(1):46-55. PubMed ID: 18032899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and analysis issues in cardiac arrhythmia trials: insights from the Detect Supraventricular Tachycardia Trial.
    McClelland RL; Bamlet WR; Glikson M; Friedman PA
    Clin Trials; 2007; 4(1):74-80. PubMed ID: 17327247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design.
    Del Boca FK; Darkes J
    Addiction; 2007 Jul; 102(7):1047-56. PubMed ID: 17567393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing the degrees of freedom in future group randomized trials: the df * method revisited.
    Murray DM; Blitstein JL; Hannan PJ; Shadish WR
    Eval Rev; 2012 Dec; 36(6):430-48. PubMed ID: 23640051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Participant-centered adaptations in caregiver trials: strategies for managing confounds.
    Davis LL; Weaver M; Habermann B; Buckwalter K
    Nurs Outlook; 2005; 53(2):73-8. PubMed ID: 15858525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.
    Leon AC; Mallinckrodt CH; Chuang-Stein C; Archibald DG; Archer GE; Chartier K
    Biol Psychiatry; 2006 Jun; 59(11):1001-5. PubMed ID: 16503329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The merits of breaking the matches: a cautionary tale.
    Donner A; Taljaard M; Klar N
    Stat Med; 2007 Apr; 26(9):2036-51. PubMed ID: 16927437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-free artificial liver support: design of appropriate clinical studies.
    Bernal W; Wendon J
    Ther Apher Dial; 2006 Apr; 10(2):175-9. PubMed ID: 16684220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methodology and reporting of randomised controlled trials.
    Jacobs WC
    Knee; 2004 Dec; 11(6):423-5. PubMed ID: 15581759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternatives to randomized controlled trials in telemedicine.
    Grigsby J; Bennett RE
    J Telemed Telecare; 2006; 12 Suppl 2():S77-84. PubMed ID: 16989679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sources and handling of losses to follow-up in parallel-group randomized clinical trials in dogs and cats: 63 trials (2000-2005).
    Brown DC
    Am J Vet Res; 2007 Jul; 68(7):694-8. PubMed ID: 17605602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ignoring the group in group-level HIV/AIDS intervention trials: a review of reported design and analytic methods.
    Pals SL; Wiegand RE; Murray DM
    AIDS; 2011 Apr; 25(7):989-96. PubMed ID: 21487252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can external and subjective information ever be used to reduce the size of randomised controlled trials?
    Tan SB; Wee J; Wong HB; Machin D
    Contemp Clin Trials; 2008 Mar; 29(2):211-9. PubMed ID: 17720629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.